• Product NameGSK1292263
• Brief DescriptionInhibitors
• Purification99.76%
• Biological ActivityGSK1292263 is a novel GPR119 agonist, showing potential for the treatment of type 2 diabetes. Phase 2.
• Target NameGPR agonist
• CAS No. 1032823-75-8
• Calculated MW 456.56
• Formulation C23H28N4O4S
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Endocrine system
  SMILES:CC(C)C1=NOC(=N1)N1CCC(COC2=CN=C(C=C2)C2=CC=C(C=C2)S(C)(=O)=O)CC1
  Pathways:Endocrinology/Hormones
  Receptor:GPR119
  Boling pt:
  Melting pt:
  Solubility:DMSO: 34 mg/mL (74.46 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Zhu X, et al. Eur J Med Chem, 2011, 46(7), 2901-2907.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting